Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Trial Underway Testing Brain-Computer Implant

Stentrode implant

The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain signals, testing the implant’s feasibility for assistive technology. . . . → Read More: Trial Underway Testing Brain-Computer Implant

Gel, Crispr Help Defeat Cancer Drug Obstacles

Crispr-Cas9 illustration

A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles

NIH Funds Augmented-Reality Endovascular System

Heart, circulation system

A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System

Gene-Editing Biotech Gains $34M in Early Funds

Sickle cell illustration

A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds

Experimental Drug Shown to Prevent Memory Loss

Neurons illustration

A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice. . . . → Read More: Experimental Drug Shown to Prevent Memory Loss

Gates Investing in HIV, Tuberculosis Immunotherapies

T-cell infected by HIV

The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA. . . . → Read More: Gates Investing in HIV, Tuberculosis Immunotherapies

Urine Test Shows Promise for Cancer Screening

Mouse urine samples

Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer. . . . → Read More: Urine Test Shows Promise for Cancer Screening

Deep Learning Techniques Speed Drug Discovery

Synthetic biology

Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days. . . . → Read More: Deep Learning Techniques Speed Drug Discovery

Patch Designed for Vaccines, Cancer Treatments

Microneedle patch

An engineering team designed a small skin patch with tiny needles that in lab mice quickly delivers vaccines and possibly treatments for melanoma. . . . → Read More: Patch Designed for Vaccines, Cancer Treatments

Small Biz Grant Funds Pre-Term Gut Microbe Therapy

Microbiome graphic

National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants. . . . → Read More: Small Biz Grant Funds Pre-Term Gut Microbe Therapy